-+ 0.00%
-+ 0.00%
-+ 0.00%

IbidenLtd And 2 Other Japanese Growth Stocks To Watch

Simply Wall St·10/01/2026 16:23:13
Listen to the news

Japanese government bond yields have jumped alongside US Treasuries, which has pushed borrowing costs higher and reminded investors how quickly funding conditions can change. That backdrop puts financially sound Japanese growth companies in a different league. Investors get exposure to potential earnings expansion without relying on cheap money to keep the story alive. This article highlights three stocks from a high growth Japanese screener that fit that bill.

The three stocks covered below are just a small sample. The full screen surfaced 75 more Japanese companies with similarly strong growth stories and balance sheets that are not discussed here. If you want to identify your own high conviction ideas, head straight to the Healthy high growth potential screener

IbidenLtd (TSE:4062)

Overview: Ibiden Co.,Ltd. is an electronics and ceramics group best known for IC package substrates and PCBs used in CPUs, data-center processors, and AI or automotive GPUs, while also running diversified automotive, industrial, housing materials, and services operations.

Operations: Ibiden generates most of its ¥441.0b revenue from Electronics at ¥264.6b, with Ceramics contributing ¥87.9b and Others adding ¥107.5b.

Market Cap: ¥6.2t

Ibiden lines up closely with the screener theme, with earnings forecast to rise 26.3% a year and revenue expected to grow 19.2% a year, helped by strong AI server and data-center substrate demand. Management has already raised guidance for fiscal 2027, although future growth still leans on how one unseen pressure shapes pricing power and capacity use.

That pricing pressure question is exactly what the IbidenLtd 2 key rewards and 2 important warning signs (1 is major!) explores so you can see where growth potential and strain may be quietly diverging.

TSE:4062 Earnings & Revenue Growth as at Oct 2026
TSE:4062 Earnings & Revenue Growth as at Oct 2026

Tokyo Electron (TSE:8035)

Overview: Tokyo Electron develops and sells semiconductor production equipment such as plasma etch, deposition, and coater/developer systems that underpin advanced chip manufacturing and support the Healthy high growth potential theme.

Operations: Tokyo Electron generates all of its ¥2,626.3b revenue from Semiconductor Production Equipment, tightly tying the business to wafer-fab investment cycles.

Market Cap: ¥26.9t

Tokyo Electron sits in the flow of capex for cutting edge fabs, so its semiconductor tools are central to the screener’s earnings growth story.

"A significant slow-down in customer capital expenditures, driven by a shift from aggressive growth to cautious yield enhancement and profitability measures, is causing a multi-quarter pause in equipment orders. This is likely to put prolonged pressure on Tokyo Electron's top-line revenue and gross profit as fab expansions are delayed across multiple key customer segments."

The key variable for Tokyo Electron is how quickly that cautious investment phase shifts back into fresh orders for advanced production lines.

When that inflection comes, the full narrative for Tokyo Electron shows how stalled capex could flip into accelerating orders and what that might mean for Tokyo Electron's next chapter.

TSE:8035 Earnings & Revenue History as at Oct 2026
TSE:8035 Earnings & Revenue History as at Oct 2026

Murata Manufacturing (TSE:6981)

Overview: Murata Manufacturing develops ceramic-based electronic components, modules, and batteries that power communications, computing, automotive, and health-focused connected devices worldwide.

Operations: Murata generates most of its ¥1.98t revenue from Components at ¥1.25t and Devices and Modules at ¥664.8b, with Others at ¥71.5b.

Market Cap: ¥14.3t

Murata Manufacturing is closely aligned with the Healthy high growth potential theme, with health-focused sensors, connectivity modules, and compact batteries at the centre of that positioning despite the broader components mix. For investors, a key consideration is how shifts in demand for wellness and medical design wins may influence margins and cash generation.

Those shifting demand patterns make it worth lining up Murata Manufacturing against the analyst forecasts for Murata Manufacturing to see where product momentum and earnings expectations might be decoupling.

TSE:6981 Earnings & Revenue Growth as at Oct 2026
TSE:6981 Earnings & Revenue Growth as at Oct 2026

Seeking Fresh Alternatives Before They Fly

Fresh ideas move fast. Breakout stories gain momentum, then the best entry points vanish while everyone chases what already ran. Scan these under the radar lists before the crowd and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.